# A Phase III Study to Evaluate Efficacy of Botulinum Toxin for Treating Epicondylitis

> **NCT03380559** · PHASE3 · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 33 (actual)

## Conditions studied

- Epicondylitis

## Interventions

- **DRUG:** Injection, botulinum toxin + corticoid
- **DRUG:** Injection, placebo of toxin + corticoid
- **DRUG:** Injection, botulinum toxin + placebo corticoid

## Key facts

- **NCT ID:** NCT03380559
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-19
- **Primary completion:** 2021-07-07
- **Final completion:** 2021-08-19
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2023-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03380559

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03380559, "A Phase III Study to Evaluate Efficacy of Botulinum Toxin for Treating Epicondylitis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03380559. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*